Outcomes of a Comprehensive, Pharmacist-Managed Injectable Anticoagulation Discharge Program for the Prophylaxis and Treatment of Venous Thromboembolism

被引:2
|
作者
Reger, Melissa A. [1 ]
Chapman, Jamie L. [2 ]
Lutomski, Dave M. [3 ,4 ]
Mueller, Eric W. [4 ,5 ]
机构
[1] Community Reg Med Ctr, Dept Pharm, Burn Surg, Fresno, CA USA
[2] Blount Mem Hosp, Dept Pharm Serv, Internal Med, Maryville, TN 37804 USA
[3] Univ Cincinnati Hlth, Univ Hosp, Dept Pharm Serv, Surg Trauma, Cincinnati, OH USA
[4] Univ Cincinnati, Clin Pharm, Div Pharm Practice, James L Winkle Coll Pharm, Cincinnati, OH USA
[5] Univ Cincinnati Hlth, Univ Hosp, Dept Pharm Serv, Crit Care, Cincinnati, OH USA
关键词
D O I
10.1177/875512251102700502
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Safe and effective transition of patients receiving injectable anticoagulation, from an inpatient to an outpatient setting, requires patient education, prescription coordination, and appropriate follow-up. Objective: To evaluate a long-standing, hospital-wide, pharmacist-managed injectable anticoagulation discharge program at an urban academic medical center. Methods: This observational study included adults discharged on an injectable anticoagulant between December 1, 2008, and February 28, 2009. The primary endpoint was program adherence, defined as percent of discharged patients whose anticoagulation therapy was coordinated by a pharmacist. Secondary endpoints included duration of patient counseling and medication procurement (including confirmation of current home supply or need for complete procurement of a full/new prescription); length of hospital stay for patients with a primary diagnosis of venous thromboembolism (VTE); and VTE recurrence and bleeding rates at 3 months. Descriptive statistics were used and are presented as proportions and mean (SD). Results: A total of 207 patients discharged on an injectable anticoagulant (3.2 discharges/day) were included. Pharmacist coordination was documented for 180 (87%) patients. Overall, pharmacists spent 37.6 (25.5) minutes per patient, including 19.4 (9.6) minutes for counseling and 19.7 (19.7) minutes for medication procurement; 150 (83%) patients required complete medication procurement lasting 21.4 (19.6) minutes. The length of hospital stay for patients with a primary diagnosis of VTE was 3.2 (2.4) days. At 3 months, 5.3% and 1.4% of assessable patients had recurrent VTE or major bleeding events, respectively. Patients with major bleeding experienced intracranial hemorrhage (n = 2) and gastrointestinal bleeding (n = 1), all beyond the first 2 weeks after discharge. Conclusions: The pharmacist-managed injectable anticoagulation discharge program was completed in a large proportion of patients. Patient education and medication procurement require the majority of time-related resources. Continual process improvement is crucial for hospitals to ensure that all patients discharged with injectable anticoagulation are assessed and receive anticoagulation education.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 48 条
  • [1] Outcomes of a pharmacist-managed medication refill program
    Billups, Sarah J.
    Delate, Thomas
    Newlon, Carey
    Schwiesow, Sarah
    Jahnke, Renee
    Nadrash, Ann
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2013, 53 (05) : 505 - 512
  • [2] Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program
    Wellman, Jessica C.
    Kraus, Peggy S.
    Burton, Bradley L.
    Ensor, Christopher R.
    Nesbit, Todd W.
    Ross, Patricia A.
    Thomas, Michelle L.
    Streiff, Michael B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (10) : 934 - 939
  • [3] Implementation and Preliminary Clinical Outcomes of a Pharmacist-managed Venous Thromboembolism Clinic for Patients Treated With Rivaroxaban Post Emergency Department Discharge
    DiRenzo, Baely M.
    Beam, Daren M.
    Kline, Jeffrey A.
    Deodhar, Karishma S.
    Weber, Zachary A.
    Davis, Christie M.
    Walroth, Todd A.
    ACADEMIC EMERGENCY MEDICINE, 2018, 25 (06) : 634 - 640
  • [4] Utility of a pharmacist-managed Anticoagulation Program in patients with congenital heart disease
    O'Neil, Meredith J.
    Garr, BreAnn N.
    Faircloth, Jenna M.
    Ciambarella, Julie A.
    Lubert, Adam M.
    Nelson, Nicole L.
    Cooper, David S.
    CARDIOLOGY IN THE YOUNG, 2024, 34 (03) : 628 - 633
  • [5] Implementation and outcomes of a pharmacist-managed clinical video telehealth anticoagulation clinic
    Singh, Lakshmi G.
    Accursi, Mallory
    Black, Karen Korch
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (01) : 70 - 73
  • [6] Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients
    Bond, C. A.
    Raehl, Cynthia L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (18) : 1935 - 1942
  • [7] A pharmacist-managed anticoagulation clinic: Six-year assessment of patient outcomes
    Willey, ML
    Chagan, L
    Sisca, TS
    Chapple, KJ
    Callahan, AK
    Crain, JL
    Kitenko, LE
    Martin, T
    Spedden, KD
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (10) : 1033 - 1037
  • [8] Pharmacist-managed rivaroxaban for acute venous thromboembolism upon emergency department discharge, with focus on utility of commercial dose pack
    Chu, Aileen
    Limberg, Jill
    Marginean, Tahnee
    Stern, Electa
    PHARMACOTHERAPY, 2017, 37 (12): : E221 - E221
  • [9] Improving patient safety through a pharmacist-managed venous thromboembolism prevention service.
    McGinley, Julie
    Schimmelpfennig, Julia
    PHARMACOTHERAPY, 2017, 37 (06): : E63 - E63
  • [10] Clinical outcomes and patient satisfaction of a pharmacist-managed, emergency department-based outpatient treatment program for venous thromboembolic disease
    Zed, Peter J.
    Filiatrault, Lyne
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2008, 10 (01) : 10 - 17